ICDD is seeking 2.5 million euros

In order to carry out its stage of pre-production and prospective validation for a labelling of in vitro diagnostic test « AD Flag* » by 2018,  ICDD is currently preparing a fundraiser of 2.5 M€. « This test is a diagnostic aid for clinics of memory to better manage patients » recalls N. Compagnone, stating that american epidemiological studies have already shown that the prescription of anti-inflammatory drugs would slow the onset of disease by 2 and a half years. « Some partners for the production of antibodies are already identified » she reveals.

* Alzeihmer Disease

To know more… 

Contact : Nathalie Compagnone <ncompagnone@icdd-sas.com>